Aelis Farma SA (EPA:AELIS)

Aelis Farma Statistics

Total Valuation

Aelis Farma has a market cap or net worth of EUR 16.32 million. The enterprise value is 14.21 million.

Market Cap	16.32M
Enterprise Value	14.21M

Important Dates

The next confirmed earnings date is Tuesday, September 15, 2026.

Earnings Date	Sep 15, 2026
Ex-Dividend Date	n/a

Share Statistics

Aelis Farma has 13.60 million shares outstanding. The number of shares has increased by 1.96% in one year.

Current Share Class	13.60M
Shares Outstanding	13.60M
Shares Change (YoY)	+1.96%
Shares Change (QoQ)	+0.59%
Owned by Insiders (%)	38.33%
Owned by Institutions (%)	2.94%
Float	3.89M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	7.83
PB Ratio	3.68
P/TBV Ratio	3.84
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-2.21
EV / Sales	6.82
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.65

Financial Position

The company has a current ratio of 4.40, with a Debt / Equity ratio of 1.49.

Current Ratio	4.40
Quick Ratio	4.13
Debt / Equity	1.49
Debt / EBITDA	n/a
Debt / FCF	-1.23
Interest Coverage	-21.61

Financial Efficiency

Return on equity (ROE) is -88.41% and return on invested capital (ROIC) is -265.50%.

Return on Equity (ROE)	-88.41%
Return on Assets (ROA)	-24.41%
Return on Invested Capital (ROIC)	-265.50%
Return on Capital Employed (ROCE)	-63.89%
Weighted Average Cost of Capital (WACC)	6.35%
Revenue Per Employee	130,250
Profits Per Employee	-402,125
Employee Count	16
Asset Turnover	0.13
Inventory Turnover	n/a

Taxes

In the past 12 months, Aelis Farma has paid 8,000 in taxes.

Income Tax	8,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +1.27% in the last 52 weeks. The beta is 0.60, so Aelis Farma's price volatility has been lower than the market average.

Beta (5Y)	0.60
52-Week Price Change	+1.27%
50-Day Moving Average	1.27
200-Day Moving Average	1.23
Relative Strength Index (RSI)	44.96
Average Volume (20 Days)	31,814

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Aelis Farma had revenue of EUR 2.08 million and -6.43 million in losses. Loss per share was -0.47.

Revenue	2.08M
Gross Profit	2.08M
Operating Income	-6.20M
Pretax Income	-6.43M
Net Income	-6.43M
EBITDA	-6.11M
EBIT	-6.20M
Loss Per Share	-0.47

Balance Sheet

The company has 8.71 million in cash and 6.61 million in debt, with a net cash position of 2.10 million or 0.15 per share.

Cash & Cash Equivalents	8.71M
Total Debt	6.61M
Net Cash	2.10M
Net Cash Per Share	0.15
Equity (Book Value)	4.44M
Book Value Per Share	0.33
Working Capital	7.95M

Cash Flow

In the last 12 months, operating cash flow was -5.35 million and capital expenditures -4,000, giving a free cash flow of -5.36 million.

Operating Cash Flow	-5.35M
Capital Expenditures	-4,000
Depreciation & Amortization	93,000
Net Borrowing	547,000
Free Cash Flow	-5.36M
FCF Per Share	-0.39

Margins

Gross Margin	100.00%
Operating Margin	-297.60%
Pretax Margin	-308.35%
Profit Margin	n/a
EBITDA Margin	-293.14%
EBIT Margin	-297.60%
FCF Margin	n/a

Dividends & Yields

Aelis Farma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.96%
Shareholder Yield	-1.96%
Earnings Yield	-39.43%
FCF Yield	-32.83%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Aelis Farma has an Altman Z-Score of -0.03 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.03
Piotroski F-Score	3